Metabolic surgery provides remission of pancreatogenic diabetes in a non-obese patient.

/10.10 15 A ence: s Sur . etessu 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 In recent years, metabolic surgery has been found to effectively provide remission of type 2 diabetes mellitus (T2DM) in obese individuals and has proven superior to intense medical therapy [1,2]. However, the results of metabolic surgery on other types of diabetes beyond T2DM are scarce, and although multiple reports have found moderate to no improvement in insulin requirements, none have found insulin independence after metabolic surgery beyond T2DM [3]. As metabolic surgeons, we have learned a great deal about the mechanisms of resolution of T2DM in obese patients. It seems reasonable and at the same time controversial to generalize some of these principles to other types of diabetes such as pancreatogenic diabetes.